Replies to post #277389 on Anavex Life Sciences Corp (AVXL)

[imho]

Investor,

No doubt the discussion will focus on SIGMAR1 and the subgroups and its relevance to AD. The question remains, what about the CDR data?

Will that also be presented at CTAD or will the company participate in another conference specific to PD and PDD, to cover the CDR result?

Companies often announce attendance to more than one conference in a single PR, which Anavex has yet to issue (for CTAD even). Perhaps they are finalizing attendance to a second conference and thus the delay in the PR? What are your thoughts on this?

IMHO